Pharmacologic Pretransplant Immunosuppression (PTIS) + Reduced Toxicity Conditioning (RTC) Allogeneic Stem Cell Transplantation in Inherited Hematologic Disorders
Condition(s):Stem Cell TransplantationLast Updated:September 21, 2023Withdrawn
Hide Studies Not Open or Pending
Condition(s):Stem Cell TransplantationLast Updated:September 21, 2023Withdrawn
Condition(s):GlioblastomaLast Updated:February 9, 2024Recruiting
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:October 17, 2019Completed
Condition(s):Leukemia; LymphomaLast Updated:October 17, 2019Completed
Condition(s):Advanced Solid TumoursLast Updated:January 9, 2024Active, not recruiting
Condition(s):LymphomaLast Updated:November 29, 2017Withdrawn
Condition(s):Acute Lymphoblastic Leukemia (ALL)Last Updated:September 30, 2016Unknown status
Condition(s):Kidney Failure, ChronicLast Updated:January 18, 2018Completed
Condition(s):Advanced Soft Tissue Sarcoma; Metastatic Soft Tissue SarcomaLast Updated:May 18, 2023Recruiting
Condition(s):LymphomaLast Updated:November 29, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.